NASDAQ:TMDX TransMedics Group (TMDX) Stock Price, News & Analysis $92.01 +1.07 (+1.18%) Closing price 11/11/2026 04:00 PM EasternExtended Trading$91.65 -0.36 (-0.39%) As of 07:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About TransMedics Group Stock (NASDAQ:TMDX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get TransMedics Group alerts:Sign Up Key Stats Today's Range$90.00▼$93.4650-Day Range$65.99▼$93.7952-Week Range$60.10▼$156.00Volume914,032 shsAverage Volume1.25 million shsMarket Capitalization$3.20 billionP/E Ratio24.93Dividend YieldN/APrice Target$113.30Consensus RatingHold Company Overview TransMedics Group, Inc. is a medical technology company focused on improving organ transplantation. Its Organ Care System (OCS) is a portable platform that perfuses donor organs with warm, oxygenated blood and nutrients while they are outside the body. The company offers OCS systems for donor hearts, lungs and livers, along with related consumables and services. The company also operates the National OCS Program in the United States, an integrated offering that combines its technology with organ procurement and transportation services. This approach is intended to support the preservation and transport of donor organs for transplant centers. Founded in 1998 and headquartered in Andover, Massachusetts, TransMedics serves transplant programs in the United States and international markets. Its founder, Waleed Hassanein, is the company’s president and chief executive officer.AI Generated. May Contain Errors. Read More TransMedics Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks86th Percentile Overall ScoreTMDX MarketRank™: 4.290026246715 of 5 starsTransMedics Group scored higher than 86% of companies evaluated by MarketBeat, and ranked 143rd out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingHold Consensus RatingTransMedics Group has received a consensus rating of Hold. The company's average rating score is 2.42, and is based on no strong buy ratings, 5 buy ratings, 7 hold ratings, and no sell ratings.Upside PotentialTransMedics Group has a consensus price target of $113.30, representing about 23.1% upside from its current price of $92.01.Amount of Analyst CoverageTransMedics Group has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about TransMedics Group's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth54.43% Earnings GrowthEarnings for TransMedics Group are expected to grow by 54.43% in the coming year, from $1.58 to $2.44 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of TransMedics Group is 24.93, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.40.Price to Earnings Ratio vs. SectorThe P/E ratio of TransMedics Group is 24.93, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 33.34.Price to Earnings Growth RatioTransMedics Group has a PEG Ratio of 1.70. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioTransMedics Group has a P/B Ratio of 5.81. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted27.45% of the float of TransMedics Group has been sold short.Short Interest Ratio / Days to CoverTransMedics Group has a short interest ratio ("days to cover") of 10.22, which indicates bearish sentiment.Change versus previous monthShort interest in TransMedics Group has recently increased by 1.24%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTransMedics Group does not currently pay a dividend.Dividend GrowthTransMedics Group does not have a long track record of dividend growth. News and Social Media2.8 / 5News Sentiment0.53 News SentimentTransMedics Group has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 33 news articles for TransMedics Group this week, compared to 5 articles on an average week.Search Interest11 people have searched for TMDX on MarketBeat in the last 30 days. This is an increase of 120% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added TransMedics Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -20% compared to the previous 30 days. Company Ownership3.1 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $109,058.00 in company stock, which represents 0.0034% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, TransMedics Group insiders have bought more of their company's stock than they have sold. Specifically, they have bought $109,058.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders6.90% of the stock of TransMedics Group is held by insiders.Percentage Held by Institutions99.67% of the stock of TransMedics Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about TransMedics Group's insider trading history. Receive TMDX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TransMedics Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TMDX Stock News HeadlinesBarclays Reaffirms Their Buy Rating on TransMedics Group (TMDX)November 11 at 2:47 PM | theglobeandmail.comTransMedics: 2027 Setting Up To Be A Pivotal YearNovember 11 at 9:48 AM | seekingalpha.comYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.November 12 at 1:00 AM | Profits Run (Ad)UBS Group Forecasts Strong Price Appreciation for TransMedics Group (NASDAQ:TMDX) StockNovember 11 at 1:43 AM | americanbankingnews.comTransMedics Group, Inc. 2026 Q3 - Results - Earnings Call PresentationNovember 10 at 6:39 PM | seekingalpha.comTransMedics: Growth Is Accelerating Again And 2027 Looks PromisingNovember 10 at 6:00 AM | seekingalpha.comTransMedics: 3 Key Takeaways for Long-Term InvestorsNovember 9 at 7:36 PM | fool.comUBS Adjusts TransMedics Group Price Target to $88 From $77, Maintains Neutral RatingNovember 9 at 1:29 PM | marketscreener.comMSee More Headlines TMDX Stock Analysis - Frequently Asked Questions How have TMDX shares performed this year? TransMedics Group's stock was trading at $121.65 at the start of the year. Since then, TMDX stock has decreased by 24.4% and is now trading at $92.01. How were TransMedics Group's earnings last quarter? TransMedics Group, Inc. (NASDAQ:TMDX) released its earnings results on Thursday, November, 5th. The company reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.30 by $0.21. The company's revenue for the quarter was up 41.1% on a year-over-year basis. Read the conference call transcript. When did TransMedics Group IPO? TransMedics Group (TMDX) raised $91 million in an initial public offering on Thursday, May 2nd 2019. The company issued 5,690,000 shares at $15.00-$17.00 per share. Morgan Stanley and J.P. Morgan served as the underwriters for the IPO and Cowen and Company and Canaccord Genuity were co-managers. Who are TransMedics Group's major shareholders? Top institutional investors of TransMedics Group include Zevenbergen Capital Investments LLC (0.77%), Congress Asset Management Co. (0.73%), Public Sector Pension Investment Board (0.45%) and Trek Financial LLC (0.42%). Insiders that own company stock include James R Tobin, Waleed H Hassanein, Nicholas Corcoran, Miriam Provost, Stephen Gordon, Tamer I Khayal, Thomas J Gunderson, David Weill, Gerardo Hernandez, Anil P Ranganath, Stephanie Lovell and Edward M Basile. View institutional ownership trends. How do I buy shares of TransMedics Group? Shares of TMDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of TransMedics Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that TransMedics Group investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), CrowdStrike (CRWD), Palantir Technologies (PLTR), MercadoLibre (MELI) and Micron Technology (MU). Company Calendar Last Earnings11/05/2026Today11/12/2026Jefferies Global Healthcare Conference11/17/202638th Annual Healthcare Conference12/01/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6d) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 6 days, TMDX's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:TMDX CIK1756262 Webwww.transmedics.com Phone(978) 552-0900FaxN/AEmployees898Year Founded1998Price Target and Rating Average Price Target for TransMedics Group$113.30 High Price Target$175.00 Low Price Target$80.00 Potential Upside/Downside+23.1%Consensus RatingHold Rating Score (0-4)2.42 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)$3.69 Trailing P/E Ratio24.93 Forward P/E Ratio37.71 P/E Growth1.7Net Income$190.29 million Net Margins19.85% Pretax Margin10.12% Return on Equity13.30% Return on Assets4.93% Debt Debt-to-Equity Ratio1.46 Current Ratio4.53 Quick Ratio4.15 Sales & Book Value Annual Sales$727.65 million Price / Sales4.39 Cash Flow$3.97 per share Price / Cash Flow23.16 Book Value$15.85 per share Price / Book5.81Miscellaneous Outstanding Shares34,734,000Free Float32,337,000Market Cap$3.20 billion OptionableOptionable Beta2.14 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:TMDX) was last updated on 11/11/2026 by MarketBeat.com Staff. From Our PartnersWatch This NowJensen Huang, the man who launched the AI boom, just called what Elon Musk is chasing "the final frontier of A...StocksToTrade | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredThis 10.3% war bond closed once. It's finally open again.Todd Phillips has spent 30 years studying safe-money income. His test for real retirement income: can it promi...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransMedics Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransMedics Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
